» Articles » PMID: 16765382

Metal Changes in CSF and Peripheral Compartments of Parkinsonian Patients

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2006 Jun 13
PMID 16765382
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Involvement of metals in the risk of developing Parkinson's disease (PD) has been suggested. In the present study, concentration of metals in cerebrospinal fluid (CSF), blood, serum, urine and hair of 91 PD patients and 18 controls were compared.

Methods: Blood and hair were microwave digested, while CSF, serum and urine were water-diluted. Elements quantification was achieved by Inductively Coupled Plasma Atomic Emission Spectrometry and Sector Field Inductively Coupled Plasma Mass Spectrometry.

Results: Some metal imbalances in PD were observed: i), in CSF, lower Fe and Si; ii), in blood, higher Ca, Cu, Fe, Mg and Zn; iii), in serum, lower Al and Cu; iv), in urine, lower Al and Mn, higher Ca and Fe; and v), in hair, lower Fe. The ROC analysis suggested that blood Ca, Fe, Mg and Zn were the best discriminators between PD and controls. In addition, hair Ca and Mg were at least 1.5 times higher in females than in males of patients and controls. A decrement with age of patients in hair and urine Ca and, with less extent, in urine Si was observed. Magnesium concentration in CSF decreased with the duration and severity of the disease. Elements were not influenced by the type of antiparkinsonian therapy.

Conclusions: Variation in elements with the disease do not exclude their involvement in the neurodegeneration of PD.

Citing Articles

Magnesium (Mg) and Neurodegeneration: A Comprehensive Overview of Studies on Mg Levels in Biological Specimens in Humans Affected Some Neurodegenerative Disorders with an Update on Therapy and Clinical Trials Supplemented with Selected Animal Studies.

Scibior A, Llopis J, Dobrakowski P, Mecik-Kronenberg T Int J Mol Sci. 2024; 25(23).

PMID: 39684308 PMC: 11641227. DOI: 10.3390/ijms252312595.


Correlations Between Dietary Magnesium Consumption and Magnesium Depletion Score in Relation to Parkinson's Disease: A Population-Based Study.

Cen Y, Wang L, Zhang S, Li X, Xu Y, Zeng Z Biol Trace Elem Res. 2024; .

PMID: 39465480 DOI: 10.1007/s12011-024-04428-6.


The Neuroprotective and Anxiolytic Effects of Magnesium Sulfate on Retinal Dopaminergic Neurons in 6-OHDA-Induced Parkinsonian Rats: A Pilot Study.

Huang L, Lin R, Zhang C, Zheng S, Wang Y, Wu Z Brain Sci. 2024; 14(9).

PMID: 39335357 PMC: 11430011. DOI: 10.3390/brainsci14090861.


The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.

Cibulka M, Brodnanova M, Halasova E, Kurca E, Kolisek M, Grofik M Int J Mol Sci. 2024; 25(15).

PMID: 39125993 PMC: 11312984. DOI: 10.3390/ijms25158425.


Dietary Copper Intake and Risk of Parkinson's Disease: a Cross-sectional Study.

Zeng Z, Cen Y, Xiong L, Hong G, Luo Y, Luo X Biol Trace Elem Res. 2023; 202(3):955-964.

PMID: 37462848 PMC: 10803382. DOI: 10.1007/s12011-023-03750-9.